Stay updated on Clinical Trial: Nivolumab in HCC with Electroporation
Sign up to get notified when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.

Latest updates to the Clinical Trial: Nivolumab in HCC with Electroporation page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedSite-wide revision updates were applied (Revision: v3.4.2) with removal of the prior funding/operating status notice (Revision: v3.4.1), which does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding status notice. Updated the site to revision v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedAdded Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0 to the page. Removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 from the page.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page footer now displays the revision notice 'Revision: v3.3.3'. References to 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision notice updated from v3.2.0 to v3.3.2 on the page; this change does not affect the study content or trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Nivolumab in HCC with Electroporation
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.